D M Dorfman

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas
    D M Dorfman
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Am J Pathol 153:255-62. 1998
  2. ncbi Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma
    D M Dorfman
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Mod Pathol 11:989-94. 1998
  3. ncbi Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor
    Y L Matory
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Pathobiology 67:186-95. 1999
  4. ncbi Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms
    M W Datta
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Appl Immunohistochem Mol Morphol 8:210-5. 2000
  5. ncbi Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation
    K T Hall
    Dana Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 93:11780-5. 1996
  6. ncbi The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia
    D Jones
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Blood 95:627-32. 2000
  7. ncbi T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumor
    Y L Matory
    Department of Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    Pathobiology 67:3-11. 1999
  8. ncbi Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor
    J L Kutok
    Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA
    Hum Pathol 32:1382-7. 2001
  9. ncbi Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells
    D M Dorfman
    Division of Hematology Oncology, Children s Hospital, Boston, Massachusetts 02115
    J Biol Chem 267:1279-85. 1992

Collaborators

Detail Information

Publications9

  1. ncbi The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas
    D M Dorfman
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Am J Pathol 153:255-62. 1998
    ..Absence of expression of CD100 by neoplastic follicular center B cells is a common feature in follicular lymphomas, but expression of CD100 by T cells is maintained in T-cell lymphoproliferative disorders...
  2. ncbi Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma
    D M Dorfman
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Mod Pathol 11:989-94. 1998
    ..We conclude that dual immunoreactivity for bcl-2 and mcl-1 is a feature of malignant neoplasms with thymic differentiation in general, both within the thymus and at ectopic sites...
  3. ncbi Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor
    Y L Matory
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Pathobiology 67:186-95. 1999
    ..In vivo (Balb/c mice) tumor growth inhibition, treatment of established tumor and the effects of ICAM-1 and CD4+ and CD8+ T cells were evaluated...
  4. ncbi Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms
    M W Datta
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Appl Immunohistochem Mol Morphol 8:210-5. 2000
    ..Based on these findings, CD74 and MHC class II are useful markers for the classification of thymic epithelial neoplasms...
  5. ncbi Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation
    K T Hall
    Dana Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA
    Proc Natl Acad Sci U S A 93:11780-5. 1996
    ..Thus, these results suggest that semaphorins as exemplified by CD100 also play a functional role in the immune system...
  6. ncbi The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia
    D Jones
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Blood 95:627-32. 2000
    ..Coexpression of CXCR3 and its ligand, Mig, may be an important functional interaction in B-CLL, as well as a useful diagnostic marker for the differential diagnosis of small cell lymphomas. (Blood. 2000;95:627-632)..
  7. ncbi T cells mediate treatment of six-day-old cytokine-gene-transfected mouse mammary tumor
    Y L Matory
    Department of Surgery, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
    Pathobiology 67:3-11. 1999
    ..Tumor infiltrating lymphocytes or cells from draining lymph nodes demonstrated tumor-specific in vitro cytotoxicity. Immunohistochemical studies revealed T cell infiltrates in transfected tumors...
  8. ncbi Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor
    J L Kutok
    Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA
    Hum Pathol 32:1382-7. 2001
    ..The absence of ALK kinase as detected by immunohistochemical studies in IPT of the lymph node and spleen suggests that this entity is biologically distinct from the histologically similar IMT...
  9. ncbi Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells
    D M Dorfman
    Division of Hematology Oncology, Children s Hospital, Boston, Massachusetts 02115
    J Biol Chem 267:1279-85. 1992
    ..We propose that GATA-2 is the GATA-binding protein required for PPET-1 gene expression in endothelial cells...